Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient

Point-Counterpoint: β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections

(2013) Elitza S. Theel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Case Report of the Reliability 1,3-β-d-Glucan Monitoring during Treatment of Peritoneal Candidiasis in a Child Receiving Continuous Peritoneal Dialysis

(2012) Francesca Ginocchio et al.   Clinical and Vaccine Immunology

(1–3)-β-D-glucan levels in candidiasis infections in the critically ill neonate

(2012) Sabrina Goudjil et al.   Journal of Maternal-Fetal & Neonatal Medicine

Diagnostic potential of nested PCR, galactomannan EIA, and Beta-D-glucan for invasive aspergillosis in pediatric patients

(2012) Parisa Badiee et al.   Journal of Infection in Developing Countries

Persistence of a Positive (1,3)-β-d-Glucan Test after Clearance of Candidemia in Hematopoietic Stem Cell Transplant Recipients

(2011) M. Mikulska et al.   Clinical and Vaccine Immunology

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

(2011) F. Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Performance of 1→3-β-D-Glucan in Neonatal and Pediatric Patients with Candidemia

(2011) Maria Teresa Montagna et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candidaspecies

(2010) Eiman Mokaddas et al.   BMC INFECTIOUS DISEASES

High Levels of  -D-Glucan in Immunocompromised Children with Proven Invasive Fungal Disease

(2010) A. Mularoni et al.   Clinical and Vaccine Immunology

The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

(2010) G. Metan et al.   INFECTION

Difficulties in using 1,3- -D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis

(2010) Z. Racil et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES